Pulse Biosciences PLSE Stock
Pulse Biosciences Price Chart
Pulse Biosciences PLSE Financial and Trading Overview
| Pulse Biosciences stock price | 16.89 USD |
| Previous Close | 6.58 USD |
| Open | 6.71 USD |
| Bid | 6.43 USD x 1200 |
| Ask | 7.3 USD x 800 |
| Day's Range | 6.51 - 7.18 USD |
| 52 Week Range | 1.18 - 9.69 USD |
| Volume | 176.18K USD |
| Avg. Volume | 121.65K USD |
| Market Cap | 309.98M USD |
| Beta (5Y Monthly) | 1.140042 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.99 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PLSE Valuation Measures
| Enterprise Value | 283.9M USD |
| Trailing P/E | N/A |
| Forward P/E | -7.2333336 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1210.8575 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1108.984 |
| Enterprise Value/EBITDA | -5.792 |
Trading Information
Pulse Biosciences Stock Price History
| Beta (5Y Monthly) | 1.140042 |
| 52-Week Change | 227.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.69 USD |
| 52 Week Low | 1.18 USD |
| 50-Day Moving Average | 6.47 USD |
| 200-Day Moving Average | 3.48 USD |
PLSE Share Statistics
| Avg. Volume (3 month) | 121.65K USD |
| Avg. Daily Volume (10-Days) | 114.81K USD |
| Shares Outstanding | 47.62M |
| Float | 12.65M |
| Short Ratio | 11.2 |
| % Held by Insiders | 57.51% |
| % Held by Institutions | 6.78% |
| Shares Short | 1.54M |
| Short % of Float | 5.91% |
| Short % of Shares Outstanding | 3.23% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -19666.40% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -57.33% |
| Return on Equity (ttm) | -1007.76% |
Income Statement
| Revenue (ttm) | 256K USD |
| Revenue Per Share (ttm) | 0.007 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -49015000 USD |
| Net Income Avi to Common (ttm) | -51033000 USD |
| Diluted EPS (ttm) | -1.59 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.1M USD |
| Total Cash Per Share (mrq) | 1.44 USD |
| Total Debt (mrq) | 75.63M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.86 |
| Book Value Per Share (mrq) | -0.284 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -37989000 USD |
| Levered Free Cash Flow (ttm) | -21516124 USD |
Profile of Pulse Biosciences
| Country | United States |
| State | CA |
| City | Hayward |
| Address | 3957 Point Eden Way |
| ZIP | 94545 |
| Phone | 510 906 4600 |
| Website | https://www.pulsebiosciences.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 61 |
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
Q&A For Pulse Biosciences Stock
What is a current PLSE stock price?
Pulse Biosciences PLSE stock price today per share is 16.89 USD.
How to purchase Pulse Biosciences stock?
You can buy PLSE shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pulse Biosciences?
The stock symbol or ticker of Pulse Biosciences is PLSE.
Which industry does the Pulse Biosciences company belong to?
The Pulse Biosciences industry is Medical Instruments & Supplies.
How many shares does Pulse Biosciences have in circulation?
The max supply of Pulse Biosciences shares is 67.27M.
What is Pulse Biosciences Price to Earnings Ratio (PE Ratio)?
Pulse Biosciences PE Ratio is now.
What was Pulse Biosciences earnings per share over the trailing 12 months (TTM)?
Pulse Biosciences EPS is -0.99 USD over the trailing 12 months.
Which sector does the Pulse Biosciences company belong to?
The Pulse Biosciences sector is Healthcare.
Pulse Biosciences PLSE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}